SCHEMBL8364321

SCHEMBL8364321

COC(=O)c1ccc(CN(C2CCCN(C(=O)C3CC3)C2)S(=O)(=O)c2ccc(Cl)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.45
HSD17B10 Q99714 1/20 0.45
LMNA P02545 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
ALDH1A1 P00352 2/20 0.45
POLB P06746 2/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
PSEN1 P49768 7/20 0.44
PSEN2 P49810 7/20 0.44
APH1B Q8WW43 7/20 0.44
NCSTN Q92542 7/20 0.44
APH1A Q96BI3 7/20 0.44
PSENEN Q9NZ42 7/20 0.44
MAPT P10636 3/20 0.44
RORC P51449 1/20 0.42
HDAC3 O15379 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8363935 0.92 MEN1 (0.46) KDM4EHSD17B10LMNASMN1; SMN2ALDH1A1
SCHEMBL8364400 0.91 ALDH1A1 (0.51) KDM4EHSD17B10LMNASMN1; SMN2ALDH1A1
SCHEMBL8363917 0.90 MEN1 (0.45) KDM4EHSD17B10LMNASMN1; SMN2ALDH1A1
SCHEMBL8364399 0.89 ALDH1A1 (0.53) KDM4EHSD17B10LMNASMN1; SMN2ALDH1A1
SCHEMBL8364380 0.89 ALDH1A1 (0.54) KDM4EHSD17B10LMNASMN1; SMN2ALDH1A1
SCHEMBL8364214 0.88 CNR1 (0.54) KDM4EHSD17B10LMNASMN1; SMN2ALDH1A1
SCHEMBL8360870 0.88 NR1D1 (0.48) KDM4EHSD17B10LMNASMN1; SMN2ALDH1A1
SCHEMBL8364220 0.88 MEN1 (0.45) KDM4EHSD17B10LMNASMN1; SMN2ALDH1A1
SCHEMBL8364270 0.87 PSEN1 (0.44) KDM4EHSD17B10LMNASMN1; SMN2ALDH1A1
SCHEMBL8363845 0.87 LMNA (0.49) KDM4EHSD17B10LMNASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003013527-A1 SULFONAMIDE DERIVATIVES AS GAMMA SECRETASE INHIBITORS SCHERING CORPORATION (US) 2003-02-20 WO disclosed